Osaic Holdings’s Enlivex Therapeutics ENLV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.42K | Sell |
2,142
-4,595
| -68% | -$5.19K | ﹤0.01% | 6425 |
|
|
2025
Q1 | $6.53K | Buy |
6,737
+6,026
| +848% | +$5.84K | ﹤0.01% | 5952 |
|
|
2024
Q4 | $832 | Buy |
711
+311
| +78% | +$364 | ﹤0.01% | 6735 |
|
|
2024
Q3 | $672 | Hold |
400
| – | – | ﹤0.01% | 6749 |
|
|
2024
Q2 | $568 | Hold |
400
| – | – | ﹤0.01% | 6755 |
|
|
2024
Q1 | $1.52K | Hold |
400
| – | – | ﹤0.01% | 6401 |
|
|
2023
Q4 | $1.08K | Hold |
400
| – | – | ﹤0.01% | 6576 |
|
|
2023
Q3 | $632 | Hold |
400
| – | – | ﹤0.01% | 6786 |
|
|
2023
Q2 | $1.05K | Hold |
400
| – | – | ﹤0.01% | 6729 |
|
|
2023
Q1 | $1.46K | Hold |
400
| – | – | ﹤0.01% | 6725 |
|
|
2022
Q4 | $2K | Hold |
400
| – | – | ﹤0.01% | 6585 |
|
|
2022
Q3 | $2K | Hold |
400
| – | – | ﹤0.01% | 6682 |
|
|
2022
Q2 | $2K | Hold |
400
| – | – | ﹤0.01% | 6794 |
|
|
2022
Q1 | $2K | Hold |
400
| – | – | ﹤0.01% | 6723 |
|
|
2021
Q4 | $3K | Sell |
400
-1,800
| -82% | -$13.5K | ﹤0.01% | 6739 |
|
|
2021
Q3 | $22K | Sell |
2,200
-300
| -12% | -$3K | ﹤0.01% | 5685 |
|
|
2021
Q2 | $22K | Buy |
2,500
+200
| +9% | +$1.76K | ﹤0.01% | 5585 |
|
|
2021
Q1 | $25K | Buy |
+2,300
| New | +$25K | ﹤0.01% | 5307 |
|